Apton Biosystems Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 15
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $22.3M
Latest Deal Amount
  • Investors
  • 4

Apton Biosystems General Information

Description

Developer of a high-speed imaging system intended for bio-marker identification and qualification. The company's molecular profiling platform is enabled by a proprietary super-resolution, combined with unique, low-cost flow cells, providing healthcare industry players and medical professionals with tools for autoimmune, inflammatory, blood, and lymphatic diseases as well as cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Diagnostic Equipment
Biotechnology
Primary Office
  • 6670 Owens Drive
  • Pleasanton, CA 94588
  • United States
+1 (925) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Apton Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 31-Aug-2019 $22.3M 000.00 000.00 Completed Product In Beta Test
1. Seed Round 18-Mar-2015 00.00 00.00 000.00 Completed Startup
To view Apton Biosystems’s complete valuation and funding history, request access »

Apton Biosystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Apton Biosystems’s complete cap table history, request access »

Apton Biosystems Executive Team (7)

Name Title Board Seat Contact Info
Ellen Beasley Ph.D Chief Executive Officer & Board Member
Scott Gorton Chief Financial Officer
Bryan Staker Co-Founder & Chief Technology Officer and Board Member
Manohar Furtado Ph.D Chief Scientific Officer & Chief Regulatory Officer
Heiner Dreismann Ph.D Chairman
You’re viewing 5 of 7 executive team members. Get the full list »

Apton Biosystems Board Members (4)

Name Representing Role Since
Ellen Beasley Ph.D Apton Biosystems Chief Executive Officer & Board Member 000 0000
Heiner Dreismann Ph.D Self Chairman 000 0000
Rajesh Swaminathan Khosla Ventures Board Member 000 0000
To view Apton Biosystems’s complete board members history, request access »

Apton Biosystems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Apton Biosystems Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cenova Capital Venture Capital Minority 000 0000 000000 0
Cowin Venture Venture Capital Minority 000 0000 000000 0
Samsung Catalyst Fund Corporate Venture Capital Minority 000 0000 000000 0
Khosla Ventures Venture Capital Minority 000 0000 000000 0
To view Apton Biosystems’s complete investors history, request access »